RAG-1 Antibodies

Santa Cruz Biotechnology delivers a wide array of RAG-1 monoclonal antibodies for research focused on understanding RAG-1's role in lymphocyte development and immune response. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).RAG-1, or Recombination Activating Gene 1, is crucial for the development of B and T lymphocytes, as it facilitates the rearrangement of immunoglobulin and T-cell receptor genes. The rearrangement process is essential for generating the diverse repertoire of antibodies and T-cell receptors necessary for adaptive immunity. Dysregulation of RAG-1 can lead to severe immunodeficiencies and has implications in various lymphoid malignancies. RAG-1 monoclonal antibodies enable detailed analysis of protein expression patterns across different cell types and tissues. Researchers can track RAG-1 localization and examine its interactions with other molecular components. Advanced visualization techniques using RAG-1 monoclonal antibodies allow for precise mapping of protein distribution in cellular compartments. Santa Cruz Biotechnology monoclonal antibodies targeting RAG-1 support researchers worldwide in advancing our understanding of immune system development and disease mechanisms.